相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dexamethasone intravitreal implant in treatment-naive diabetic macular oedema: findings from the prospective, multicentre, AUSSIEDEX study
Samantha Fraser-Bell et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2023)
Persistent diabetic macular edema: Definition, incidence, biomarkers, and treatment methods
Osama A. Sorour et al.
SURVEY OF OPHTHALMOLOGY (2023)
Results of dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema patients: Early versus late switch
Jorge Ruiz-Medrano et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2021)
Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes
Pedro Neves et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2021)
Early versus late switch: How long should we extend the anti-vascular endothelial growth factor therapy in unresponsive diabetic macular edema patients?
Adrian Hernandez Martinez et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2020)
Use of intravitreal dexamethasone implants in the treatment of diabetic macular edema: Expert recommendations using a Delphi approach
Alfredo Garcia Layana et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2020)
Diabetic Retinopathy Preferred Practice Pattern®
Timothy W. Olsen et al.
OPHTHALMOLOGY (2020)
Early and Late Switch from Ranibizumab to an Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema in the Event of a Poor Anatomical Response
Gokhan Demir et al.
CLINICAL DRUG INVESTIGATION (2020)
ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA An Independent Analysis of Protocol i Study Data
Pravin U. Dugel et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2019)
Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
Catharina Busch et al.
ACTA DIABETOLOGICA (2019)
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
Catharina Busch et al.
ACTA DIABETOLOGICA (2018)
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema A DRCR Network Phase 2 Randomized Clinical Trial
Raj K. Maturi et al.
JAMA OPHTHALMOLOGY (2018)
Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant
Pierluigi Iacono et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2017)
A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
David G. Callanan et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2017)
Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGICA (2017)
Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome
Irini Chatziralli et al.
DIABETES THERAPY (2017)
Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data from a Prospective Study and Predictive Factors for Visual Outcome
Irini Chatziralli et al.
DIABETES THERAPY (2017)
A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study)
Ling Zhi Heng et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
Early and Long-Term Responses to Anti Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data
Victor H. Gonzalez et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Diabetic macular oedema: pathophysiology, management challenges and treatment resistance
Bobak Bahrami et al.
DIABETOLOGIA (2016)
PROSPECTIVE RANDOMIZED SUBJECT-MASKED STUDY OF INTRAVITREAL BEVACIZUMAB MONOTHERAPY VERSUS DEXAMETHASONE IMPLANT MONOTHERAPY IN THE TREATMENT OF PERSISTENT DIABETIC MACULAR EDEMA
Sanket U. Shah et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2016)
Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular Edema
Carmen A. Puliafito et al.
Ophthalmic Surgery Lasers & Imaging Retina (2016)
Dexamethasone intravitreal implant for diabetic macular edema: indications for a PRN regimen of treatment
Giacomo Panozzo et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2015)
A review of therapies for diabetic macular oedema and rationale for combination therapy
W. M. K. Amoaku et al.
EYE (2015)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
John A. Wells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Dexamethasone Implants in Patients with Naive or Refractory Diffuse Diabetic Macular Edema
Jose Juan Escobar-Barranco et al.
OPHTHALMOLOGICA (2015)
The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates
Brian L. VanderBeek et al.
OPHTHALMOLOGY (2015)
Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1)
R. Mathew et al.
EYE (2014)
A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema The BEVORDEX Study
Mark C. Gillies et al.
OPHTHALMOLOGY (2014)
Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
David S. Boyer et al.
OPHTHALMOLOGY (2014)
Dexamethasone Intravitreal Implant in Combination with Laser Photocoagulation for the Treatment of Diffuse Diabetic Macular Edema
David G. Callanan et al.
OPHTHALMOLOGY (2013)
分享论文
